Caladrius Biosciences Inc...

NASDAQ: CLBS · Real-Time Price · USD
0.43
-0.08 (-16.05%)
At close: Sep 15, 2022, 6:00 AM

Caladrius Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Net Income
-27.47M
Depreciation & Amortization
55K
Stock-Based Compensation
n/a
Other Working Capital
-603K
Other Non-Cash Items
4.52M
Deferred Income Tax
-2M
Change in Working Capital
647K
Operating Cash Flow
-22.25M
Capital Expenditures
-60K
Cash Acquisitions
n/a
Purchase of Investments
-179.78M
Sales Maturities Of Investments
124.94M
Other Investing Acitivies
n/a
Investing Cash Flow
-54.9M
Debt Repayment
n/a
Common Stock Repurchased
n/a
Dividend Paid
n/a
Other Financial Acitivies
85.28M
Financial Cash Flow
85.28M
Net Cash Flow
8.13M
Free Cash Flow
-22.3M